| Table
|
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary
tumor histology
| Teratoma-positive
| Teratoma-negative
|
|||||||||||
Prechemotherapy
HCG
| <1000
| 1000-10000
| >10000
IU/I
| <1000
| 1000-10000
| >10000
IU/I
|
|||||||
Single,
unilateral residual nodule?
| Y
| N
| Y
| N
| Y
| N
| Y
| N
| Y
| N
| Y
| N
|
|
Prechemotherapy
AFP elevated
| Nec
| 61%
| 36%
| 81%
| 60%
| 92%
| 80%
| 83%
| 63%
| 93%
| 83%
| 97%
| 93%
|
Nec
| 49%
| 26%
| 72%
| 48%
| 87%
| 71%
| 76%
| 53%
| 89%
| 75%
| 96%
| 89%
|
|
| Example of a table with predicted probabilities based on a logistic regression model. The probability of necrosis (fully benign tissue) is shown for patients undergoing resection or residual lung metastases after chemotherapy treatment for testicular cancer. The continuous predictor 'Prechemotherapy HCG' was categorized as <1000, 1000-10000, or >10000 IU/I. | |||||||||||||